While adopting a cloud approach has certainly been part of the conversation for the industry, the velocity with which Pharma organizations are researching and navigating their move to the cloud is seeing a shift. This is driven by observed cloud successes within selected business functions, coupled with learnings from other industry trailblazers who are sharing their approaches and best practices.
As part of Appian's Industry Outlook Podcast series, I sat down to discuss the trends and considerations impacting Life Sciences. In the final part of this 3-part series, I dive a bit deeper to discuss how Pharma is evaluating and adopting a cloud approach, covering topics like:
Listen to part 3 below as I discuss these topics and more around the impressions, attitude and atmosphere for Life Sciences and the move to the cloud.
Missed parts 1 and 2 of this series? Take a listen at the links below:
Here I discuss predictions around the technology, innovation and other forces shaping the Life Sciences Industry
In Part 2, I take a thorough look at the stages and systems that support the product lifecycle and the importance of accelerating these processes
VP, Global Pharma & Life Sciences
Appian is the unified platform for change. We accelerate customers’ businesses by discovering, designing, and automating their most important processes. The Appian Low-Code Platform combines the key capabilities needed to get work done faster, Process Mining + Workflow + Automation, in a unified low-code platform. Appian is open, enterprise-grade, and trusted by industry leaders.